Allergen, Individual-Animal Swine/Pig Epithelium E6

The Allergen, Individual-Animal Swine/Pig Epithelium E6 test is a laboratory assay that measures specific IgE antibodies to pig (swine) epithelium, identifying sensitization to porcine epithelium proteins. Performed on a blood sample collected at home or in-clinic, the test quantifies IgE levels to determine whether an immune response to pig epithelium is present and to what degree.

This test is useful for people with respiratory or contact allergy symptoms linked to pig exposure—such as farmers, abattoir workers, veterinarians, or individuals who keep pigs as pets—and for clinicians in Dubai and across the UAE to guide avoidance strategies, workplace adjustments, or further allergy management. A positive result indicates sensitization but must be interpreted alongside clinical history; consult an allergist or physician for diagnosis and treatment planning.

• Swine/Pig epithelium-specific IgE (E6)
• Quantitative IgE concentration (kU/L)
• Sensitization class/grade (e.g., class 0–6)
• Result interpretation note (Positive/Negative with clinical correlation)

• Recurrent rhinitis, sneezing or itchy eyes after pig exposure
• New or worsening asthma symptoms in swine environments
• Occupational exposure (farms, abattoirs, veterinary practice, meat processing)
• Contact urticaria or dermatitis after handling pigs or pork epithelium
• Pre-evaluation to guide allergen avoidance or possible immunotherapy decisions

• Accurate identification of sensitization to pig (swine) epithelium
• Quantitative results to guide clinical decisions and monitoring
• Convenient home sample collection and laboratory analysis across Dubai and the UAE
• Supports occupational health assessments and workplace accommodations
• Clear laboratory report suitable for follow-up with UAE-based allergists

• Home blood sample collection (finger-prick or venous) by trained phlebotomist
• No fasting required; routine medications can usually be continued
• Inform the lab/clinician if you are receiving allergen immunotherapy, biologics (e.g., omalizumab) or immunosuppressants
• Provide valid UAE ID, consent, and a brief exposure history for accurate interpretation